01 1Seroxat
02 1Seroxat/ Paxil
03 6Seroxat/Paxil
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 202
2019 Revenue in Millions : 222
Growth (%) : -9
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 173
2020 Revenue in Millions : 200
Growth (%) : -12
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 298
2014 Revenue in Millions : 234
Growth (%) : -21%
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -26.30%
2013 Revenue in Millions :
Growth (%) :
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 255
2015 Revenue in Millions : 205
Growth (%) : 25
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 259
2016 Revenue in Millions : 290
Growth (%) : -11
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 226
2017 Revenue in Millions : 245
Growth (%) : -8%
Paroxetine Hydrochloride Hemihydrate
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 198
2018 Revenue in Millions : 211
Growth (%) : -6
LOOKING FOR A SUPPLIER?